Obstetrical and Neonatal Outcomes Among Women Infected With Hepatitis C and Their Infants

Journal of Obstetrics and Gynaecology Canada

Volumn 36, Issue 9, 2014, Pages 785-794

  Money, Deborah ^a,b   Boucoiran, Isabelle ^a,b   Wagner, Emily ^b   Dobson, Simon ^c   Kennedy, Aaron ^a   Lohn, Zoe ^b   Krajden, Mel ^d   Yoshida, Eric M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b WOMEN S HEALTH RESEARCH INSTITUTE   (Canada)

^c BC CHILDREN S HOSPITAL   (Canada)

^d BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

Author keywords

Competing interests: None declared; HCV RNA; Hepatitis C; Pregnancy; Preterm delivery; Small for gestational age

Indexed keywords

ALANINE AMINOTRANSFERASE; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; BRITISH COLUMBIA; CHOLESTASIS; FEMALE; FETUS DEATH; HEPATITIS C; HUMAN; INFANT; LONGITUDINAL STUDY; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NEWBORN; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PROSPECTIVE STUDY; SMALL FOR DATE INFANT; VERTICAL TRANSMISSION; VIRUS LOAD; YOUNG ADULT; CANADA; FETUS MORTALITY; GENETICS; HEPACIVIRUS; MASS SCREENING; NEEDS ASSESSMENT; ORGANIZATION AND MANAGEMENT; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREMATURE BIRTH; PREVENTION AND CONTROL; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TRANSMISSION;

ADULT; BRITISH COLUMBIA; FEMALE; FETAL MORTALITY; HEPACIVIRUS; HEPATITIS C; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MASS SCREENING; NEEDS ASSESSMENT; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PREMATURE BIRTH; PROSPECTIVE STUDIES; RISK FACTORS; RNA, VIRAL;

EID: 84925582249     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(15)30480-1     Document Type: Article

References (42)

1. Remis R.S. Modelling the incidence and prevalence of hepatitis C infection and its sequelae in Canada. Community Acquired Infections Division Centre for Communicable Diseases and Infection Control Infectious Disease and Emergency Preparedness Branch 2007, Public Health Agency of Canada, Ottawa.
2. Public Health Agency of Canada Hepatitis C in Canada: 2005-2010 Surveillance Report 2012, PHAC, Ottawa.
3. Blasig A., Wagner E.C., Pi D., Bigham M., Remple V.P., Craib K.J., BC HCV Vertical Transmission Study Group, et al. Hepatitis C infection among pregnant women in British Columbia: reported prevalence and critical appraisal of current prenatal screening methods. Can J Public Health 2011, 102:98-102.
4. Boucher M., Gruslin A. SOGC Working Group. The reproductive care of women living with hepatitis C infection. SOGC Clinical Practice Guideline no. 96, October 2000. J Obstet Gynaecol Can 2000, 22(10):820-845.
5. Gervais A., Bacq Y., Bernuau J., Martinot M., Auperin A., Boyer N., et al. Decrease in serum ALT and increase in serum HCV RNA during pregnancy in women with chronic hepatitis C. J Hepatol 2000, 32(2):293-299.
6. Latt N.C., Spencer J.D., Beeby P.J., McCaughan G.W., Saunders J.B., Collins E., et al. Hepatitis C in injecting drug-using women during and after pregnancy. J Gastroenterol Hepatol 2000, 15(2):175-181.
7. Conte D.M., Fraquelli D., Prati A., Colucci A., Minola E. Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15 250 pregnant women. Hepatology 2000, 31(3):751-755.
8. Connell L.E., Salihu H.M., Salemi J.L., August E.M., Weldeselasse H., Mbah A.K. Maternal hepatitis B and hepatitis C carrier status and perinatal outcomes. Liver Int 2011, 31(8):1163-1170.
9. Berkley E.M., Leslie K.K., Arora S., Qualls C., Dunkelberg J.C. Chronic hepatitis C in pregnancy. Obstet Gynecol 2008, 112(2 Pt 1):304-310.
10. Hillemanns P., Dannecker C., Kimmig R., Hasbargen U. Obstetric risks and vertical transmission of hepatitis C virus infection in pregnancy. Acta Obstet Gynecol Scand 2000, 79(7):543-547.
11. Locatelli A., Roncaglia N., Arreghini A., Bellini P., Vergani P., Ghidini A. Hepatitis C virus infection is associated with a higher incidence of cholestasis of pregnancy. Br J Obstet Gynaecol 1999, 106(5):498-500.
12. Jaffery T., Tariq N., Ayub R., Yawar A. Frequency of hepatitis C in pregnancy and pregnancy outcome. J Coll Physicians Surg Pak 2005, 15(11):716-719.
13. Pergam S.A., Wang C.C., Gardella C.M., Sandison T.G., Phipps W.T., Hawes S.E. Pregnancy complications associated with hepatitis C: data from a 2003-2005 Washington state birth cohort. Am J Obstet Gynecol 2008, 199(1):e1-38. e9, 38.
14. Paternoster D.M., Fabris F., Palu G., Santarossa C., Bracciante R., Snijders D., et al. Intra-hepatic cholestasis of pregnancy in hepatitis C virus infection. Acta Obstet Gynecol Scand 2002, 81(2):99-103.
15. Reddick K.L., Jhaveri R., Gandhi M., James A.H., Swamy G.K. Pregnancy outcomes associated with viral hepatitis. J Viral Hepat 2011, 18(7):e394-8.
16. Prasad M.R., Honegger J.R. Hepatitis C virus in pregnancy. Am J Perinatol 2013, 30(2):149-159.
17. Le Campion A., Larouche A., Fauteux-Daniel S., Soudeyns H. Pathogenesis of hepatitis C during pregnancy and childhood. Viruses 2012, 4(12):3531-3550.
18. Everson G.T., Sims K.D., Rodriguez-Torres M., Hezode C., Lawitz E., Bourliere M., et al. Efficacy of an interferon- and ribavirin-free regimen of daclatasvir, asunaprevir, and BMS-791325 in treatment-naive patients with HCV genotype 1 infection. Gastroenterology 2014 Feb, 146(2):420-429. Epub 2013 Oct 30. 10.1053/j.gastr0.2013.10.057.
19. Vallet-Pichard A., Mallet V., Nalpas B., Verkarre V., Nalpas A., Dhalluin-Venier V., et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology 2007, 46(1):32-36.
20. Kierans W., Kramer M., Wilkins R., Liston R., Foster L., Uh S.-H., et al. Charting birth outcome in British Columbia: determinants of optimal health and ultimate risk: an expansion and update 2003, Available at, Perinatal Services BC, Vancouver, Accessed December 9, 2013. http://www.perinatalservicesbc.ca/ForHealthcareProviders/Resources/BirthWeightCharts/default.htm.
21. Redline R.W., Faye-Petersen O., Heller D., Qureshi F., Savell V., Vogler C. Amniotic infection syndrome: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 2003, 6(5):435-448.
22. Buresi M.C., Lee J., Gill S., Kong J.M., Money D.M., Yoshida E.M., et al. The prevalence of gestational diabetes mellitus and glucose abnormalities in pregnant women with hepatitis C virus infection in British Columbia. J Obstet Gynaecol Can 2010, 32(10):935-941.
23. Gibb D.M., Goodall R.L., Dunn D.T., Healy M., Neave P., Cafferkey M., et al. Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission. Lancet 2000, 356(9233):904-907.
24. Rhone S.A., Magee F., Remple V., Money D. The association of placental abnormalities with maternal and neonatal clinical findings: a retrospective cohort study. J Obstet Gynaecol Can 2003, 25(2):123-128.
25. Roberts D.J., Oliva E. Clinical significance of placental examination in perinatal medicine. J Matern Fetal Neonatal Med 2006, 19(5):255-264.
26. Joshi D., James A., Quaglia A., Westbrook R.H., Heneghan M.A. Liver disease in pregnancy. Lancet 2010, 375(9714):594-605.
27. Jabeen T., Cannon B., Hogan J., Crowley M., Devereux C., Fanning L., et al. Pregnancy and pregnancy outcome in hepatitis C type 1b. QJM 2000, 93(9):597-601.
28. Paternoster D.M., Santarossa C., Grella P., Palu G., Baldo V., Boccagni P., et al. Viral load in HCV RNA-positive pregnant women. Am J Gastroenterol 2001, 96(9):2751-2754.
29. Grange J.D., Abergel A., Amiot X., Chaslin-Ferbus D., Aygalenq P., Fouqueray B., et al. Interactions between chronic viral hepatitis C and pregnancy. Gastroenterologie clinique et biologique 1995, 19(5):520-524.
30. Arshad M., El-Kamary S.S., Jhaveri R. Hepatitis C virus infection during pregnancy and the newborn period-are they opportunities for treatment?. J Viral Hepat 2011, 18(4):229-236.
31. Fontaine H., Nalpas B., Carnot F., Brechot C., Pol S. Effect of pregnancy on chronic hepatitis C: a case-control study. Lancet 2000, 356(9238):1328-1329.
32. Remis R.S. A study to characterize the epidemiology of hepatitis C infection in Canada. Final report 2002, Public Health Agency of Canada, Ottawa.
33. Boaz K., Fiore A.E., Schrag S.J., Gonik B., Schulkin J. Screening and counseling practices reported by obstetrician-gynecologists for patients with hepatitis C virus infection. Infect Dis Obstet Gynecol 2003, 11(1):39-44.
34. Urbanus A.T., van Keep M., Matser A.A., Rozenbaum M.H., Weegink C.J., van den Hoek A., et al. Is adding HCV screening to the antenatal national screening program in Amsterdam, the Netherlands, cost-effective?. PLoS One 2013, 8(8):e70319.
35. Plunkett B.A., Grobman W.A. Routine hepatitis C virus screening in pregnancy: a cost-effectiveness analysis. Am J Obstet Gynecol 2005, 192(4):1153-1161.
36. National Institutes of Health NIH consensus statement on management of hepatitic C. NIH Consensus and State-of-the-Science Statements 2002, 19(3):1-46.
37. Resti M., Azzari C., Galli L., Zuin G., Giacchino R., Bortolotti F., et al. Maternal drug use is a preeminent risk factor for mother-to-child hepatitis C virus transmission: results from a multicenter study of 1372 mother-infant pairs. J Infect Dis 2002, 185(5):567-572.
38. AbdulQawi K., Youssef A., Metwally M.A., Ragih I., AbdulHamid M., Shaheen A. Prospective study of prevalence and risk factors for hepatitis C in pregnant Egyptian women and its transmission to their infants. Croat Med J 2010, 51(3):219-228.
39. Mast E.E., Hwang L.Y., Seto D.S., Nolte F.S., Nainan O.V., Wurtzel H., et al. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J Infect Dis 2005, 192(11):1880-1889.
40. Eriksen N.L. Perinatal consequences of hepatitis C. Clin Obstet Gynecol 1999, 42(1):121-133. quiz 174-5.
41. European Paediatric Hepatitis C Virus Network A significant sex-but not elective cesarean section-effect on mother-to-child transmission of hepatitis C virus infection. J Infect Dis 2005, 192(11):1872-1879.
42. Ohto H.S., Terazawa N., Sasaki K., Hino C., Ishiwata M., Kako, et al. ransmission of hepatitis C virus from mothers to infants. The Vertical Transmission of Hepatitis C Virus Collaborative Study Group. N Engl J Med 1994, 330(11):744-750.